Antidepressant Fluvoxamine Significantly Reduces Covid-19 Hospitalization

Antidepressant Fluvoxamine Significantly Reduces Covid-19 Hospitalization
·4 min read

Patients who received the low-cost and widely available drug were far less likely to be hospitalized in a clinical trial.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting